Case report: SAF-189s is a potent inhibitor in a lorlatinib-resistant NSCLC patient with acquired compound mutations ALK L1196M and D1203N

Overview of attention for article published in Frontiers in Pharmacology, December 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 1 X user

reddit: 1 Redditor

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

The most recent citing publication is shown below. View this citation on Dimensions.

Multiple drugs

Article in Reactions Weekly (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.